Perthera, Inc., along with UVA and EVMS, has been awarded a $500,000 Matching Grant by Virginia Catalyst to advance the delivery and effectiveness of Precision Medicine and the care of cancer patients in Virginia. The turn-key Perthera Precision Oncology Platform …Read more »
Pilot Growth Management LLC, a technology-focused growth equity firm, today announced the full deployment and final closing of Pilot Growth Equity Fund II, LP (“PGE II”). The total amount of new capital in PGE II is $45 million. Pilot Growth …Read more »
Private-equity firms often employ herds of junior employees to comb through and cold-call companies to source deals. But technology-focused Pilot Growth Equity Partners has found that a system using artificial intelligence can do the job just as well. The San …Read more »
RIDGEFIELD, Conn.–(BUSINESS WIRE)–May 21, 2019– r4 Technologies Inc., the leading provider of cross-enterprise AI software, today announced the launch of XEM(TM), its cloud-based AI product that delivers breakthrough business outcomes. Working across industries including CPG, retail, financial services, talent management …Read more »
A new global index offers an original way to monitor national-level preparedness for infectious disease, providing a holistic view of a country’s capacity to mitigate the spread of illness and pandemics. Created by researchers at Metabiota, the Epidemic Preparedness Index (EPI) …Read more »
Epidemic risk is a major threat. In the last decade, there have been over 400 high-priority human disease outbreaks which have impacted the stability of economies and corporations. The Zika virus alone may end up costing Latin America and the Caribbean up to $18bn, and the South Korean MERS outbreak in 2015 caused a 40% drop in tourism, leading to an estimated $900m drop in revenue.
Metabiota has created a comprehensive and objective methodology for quantifying the potential impact of epidemic risk. The company’s methodology comprises both data experts and on-the-ground specialists. It provides underwriters with tools to analyse and quantify the financial impact of epidemics for use in their underwriting processes. Separately, it works with industry (e.g. sports clubs) to understand the impact of epidemics on their businesses.Read more »
Perthera, Inc., the leading cancer therapeutic intelligence company, announced that Gary L. Gregory has joined the company as its Chief Executive Officer, President and Board Member.
Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts.Read more »